Cargando…
Longitudinal Nasopharyngeal Carriage and Antibiotic Resistance of Respiratory Bacteria in Indigenous Australian and Alaska Native Children with Bronchiectasis
BACKGROUND: Indigenous children in Australia and Alaska have very high rates of chronic suppurative lung disease (CSLD)/bronchiectasis. Antibiotics, including frequent or long-term azithromycin in Australia and short-term beta-lactam therapy in both countries, are often prescribed to treat these pat...
Autores principales: | Hare, Kim M., Singleton, Rosalyn J., Grimwood, Keith, Valery, Patricia C., Cheng, Allen C., Morris, Peter S., Leach, Amanda J., Smith-Vaughan, Heidi C., Chatfield, Mark, Redding, Greg, Reasonover, Alisa L., McCallum, Gabrielle B., Chikoyak, Lori, McDonald, Malcolm I., Brown, Ngiare, Torzillo, Paul J., Chang, Anne B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734249/ https://www.ncbi.nlm.nih.gov/pubmed/23940582 http://dx.doi.org/10.1371/journal.pone.0070478 |
Ejemplares similares
-
Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial
por: Valery, Patricia C, et al.
Publicado: (2012) -
641. Carriage and Genetics of Haemophilus influenzae Serotype A (Hia) in Alaska, 2018
por: Nolen, Leisha, et al.
Publicado: (2020) -
Adult outcomes of childhood bronchiectasis
por: Sibanda, Dawn, et al.
Publicado: (2020) -
Perspective: Using Bronchiectasis Action Management Plans for Children With Bronchiectasis—Can It Improve Clinical Care?
por: Schutz, Kobi L., et al.
Publicado: (2019) -
Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
por: Goyal, Vikas, et al.
Publicado: (2019)